Home > Financial Ratios > NATCO PHARMA

NATCO PHARMA
Total Debt/Equity

    Back to All Ratios
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Total Debt/Equity History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Total Debt/Equity(x) 0.060.030.090.060.08

What is the latest Total Debt/Equity ratio of NATCO PHARMA ?

The latest Total Debt/Equity ratio of NATCO PHARMA is 0.06 based on Mar2024 Consolidated results.
Year Total Debt/Equity
Mar20240.06
Mar20230.03
Mar20220.09
Mar20210.06
Mar20200.08

How is Total Debt/Equity of NATCO PHARMA Trending?

Years Total Debt/Equity % Change
Mar2024 0.06
100.00
Mar2023 0.03
-66.67
Mar2022 0.09
50.00
Mar2021 0.06
-25.00
Mar2020 0.08 -

Other Financial Ratios of NATCO PHARMA


Compare Total Debt/Equity ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹22,926.6 Cr 13.5% 6.7% 54.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,697.0 Cr 0.6% -2.1% 16.5% Stock Analytics
DIVIS LABORATORIES ₹157,449.0 Cr 4.3% 6.5% 63.9% Stock Analytics
CIPLA ₹117,778.0 Cr 3.6% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,871.0 Cr 3% -8.4% 0% Stock Analytics
ZYDUS LIFESCIENCES ₹97,046.2 Cr 3.2% -1% 27.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

13.5%

6.7%

54.6%

SENSEX

0.2%

-0.1%

7.2%


You may also like the below Video Courses